Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1842 1
1845 1
1857 1
1927 1
1930 3
1931 2
1932 3
1935 3
1937 1
1938 1
1940 1
1941 1
1942 1
1946 1
1947 2
1948 2
1951 3
1952 5
1953 1
1955 3
1956 1
1957 2
1958 2
1960 1
1961 2
1963 1
1965 1
1967 2
1970 2
1971 3
1972 2
1973 2
1974 5
1975 3
1976 4
1977 4
1978 9
1979 3
1980 3
1981 7
1982 6
1983 1
1984 2
1985 8
1986 4
1987 3
1988 1
1989 2
1990 4
1991 6
1992 9
1993 1
1995 4
1996 7
1997 7
1998 9
1999 4
2000 15
2001 9
2002 13
2003 12
2004 9
2005 8
2006 14
2007 14
2008 14
2009 16
2010 22
2011 30
2012 24
2013 30
2014 41
2015 36
2016 26
2017 40
2018 38
2019 31
2020 40
2021 60
2022 55
2023 36
2024 57

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

778 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, Mikhael J, Terpos E, Schjesvold F, Martin T, Yong K, Durie BGM, Facon T, Jurczyszyn A, Sidana S, Raje N, van de Donk N, Lonial S, Cavo M, Kristinsson SY, Lentzsch S, Hajek R, Anderson KC, João C, Einsele H, Sonneveld P, Engelhardt M, Fonseca R, Vangsted A, Weisel K, Baz R, Hungria V, Berdeja JG, Leal da Costa F, Maiolino A, Waage A, Vesole DH, Ocio EM, Quach H, Driessen C, Bladé J, Leleu X, Riva E, Bergsagel PL, Hou J, Chng WJ, Mellqvist UH, Dytfeld D, Harousseau JL, Goldschmidt H, Laubach J, Munshi NC, Gay F, Beksac M, Costa LJ, Kaiser M, Hari P, Boccadoro M, Usmani SZ, Zweegman S, Holstein S, Sezer O, Harrison S, Nahi H, Cook G, Mateos MV, Rajkumar SV, Dimopoulos MA, Richardson PG. Moreau P, et al. Among authors: davies f. Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7. Lancet Oncol. 2021. PMID: 33662288 Review.
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
Maura F, Rajanna AR, Ziccheddu B, Poos AM, Derkach A, Maclachlan K, Durante M, Diamond B, Papadimitriou M, Davies F, Boyle EM, Walker B, Hultcrantz M, Silva A, Hampton O, Teer JK, Siegel EM, Bolli N, Jackson GH, Kaiser M, Pawlyn C, Cook G, Kazandjian D, Stein C, Chesi M, Bergsagel L, Mai EK, Goldschmidt H, Weisel KC, Fenk R, Raab MS, Van Rhee F, Usmani S, Shain KH, Weinhold N, Morgan G, Landgren O. Maura F, et al. Among authors: davies f. J Clin Oncol. 2024 Apr 10;42(11):1229-1240. doi: 10.1200/JCO.23.01277. Epub 2024 Jan 9. J Clin Oncol. 2024. PMID: 38194610 Free PMC article.
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
Maura F, Boyle EM, Coffey D, Maclachlan K, Gagler D, Diamond B, Ghamlouch H, Blaney P, Ziccheddu B, Cirrincione A, Chojnacka M, Wang Y, Siegel A, Hoffman JE, Kazandjian D, Hassoun H, Guzman E, Mailankody S, Shah UA, Tan C, Hultcrantz M, Scordo M, Shah GL, Landau H, Chung DJ, Giralt S, Zhang Y, Arbini A, Gao Q, Roshal M, Dogan A, Lesokhin AM, Davies FE, Usmani SZ, Korde N, Morgan GJ, Landgren O. Maura F, et al. Among authors: davies fe. Nat Cancer. 2023 Dec;4(12):1660-1674. doi: 10.1038/s43018-023-00657-1. Epub 2023 Nov 9. Nat Cancer. 2023. PMID: 37945755
Approach to High-Risk Multiple Myeloma.
Chen X, Varma G, Davies F, Morgan G. Chen X, et al. Among authors: davies f. Hematol Oncol Clin North Am. 2024 Apr;38(2):497-510. doi: 10.1016/j.hoc.2023.12.008. Epub 2024 Jan 8. Hematol Oncol Clin North Am. 2024. PMID: 38195306 Review.
IFEM white paper on gender diversity and inclusion.
Galletta G, Hobgood C, Sheppard G, Davies F, Marathe P, McCarthy S, Subhan I, Geduld H. Galletta G, et al. Among authors: davies f. CJEM. 2022 Nov;24(7):682-684. doi: 10.1007/s43678-022-00379-w. Epub 2022 Aug 30. CJEM. 2022. PMID: 36040686 Free PMC article. No abstract available.
Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study.
Gordan LN, Tan CR, Vescio R, Ye JC, Schinke C, Medhekar R, Fu AZ, Lafeuille MH, Thompson-Leduc P, Khare V, Reitan J, Milkovich G, Kaila S, Davies F, Usmani SZ. Gordan LN, et al. Among authors: davies f. Clin Lymphoma Myeloma Leuk. 2024 Jan;24(1):55-63. doi: 10.1016/j.clml.2023.09.003. Epub 2023 Sep 14. Clin Lymphoma Myeloma Leuk. 2024. PMID: 37838502 Free article.
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm.
Pawlyn C, Schjesvold FH, Cairns DA, Wei LJ, Davies F, Nadeem O, Abdulhaq H, Mateos MV, Laubach J, Weisel K, Ludwig H, Rajkumar SV, Sonneveld P, Jackson G, Morgan G, Richardson PG. Pawlyn C, et al. Among authors: davies f. Blood Cancer J. 2024 Aug 12;14(1):134. doi: 10.1038/s41408-024-01109-4. Blood Cancer J. 2024. PMID: 39134544 Free PMC article. Review.
778 results